Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Thymoglobulin and Melphalan in Patients With Relapsed Multiple Myeloma

NCT00635024 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00635024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00635024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Thymoglobulin and Melphalan in Patients With Relapsed Multiple Myeloma
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2008
Completion date
November 30, 2010
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm